Nebivolol Teva Uk

Nebivolol, the active ingredient in Nebivolol Teva Uk, is a beta‑blocker presented as a tablet for oral use. It is prescribed to lower high blood pressure in adult patients. GNH USA supplies Nebivolol Teva Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic antagonist used primarily in the management of hypertension. - Hypertension: reduces systolic and diastolic blood pressure, helping to prevent cardiovascular complications. - Chronic heart failure (off‑label in some regions): may improve ventricular function and symptoms when used under specialist supervision. - Elderly patients with isolated systolic hypertension: provides blood‑pressure control with a favorable heart‑rate profile.

Nebivolol may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness: especially after the first dose. - Fatigue: a feeling of reduced energy. - Nasal congestion: occasional blockage of nasal passages. - Bradycardia: slower than normal heart rate. - Gastrointestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects: - Severe bradycardia: heart rate markedly below normal. - Acute heart failure decompensation. - Bronchospasm: especially in patients with reactive airway disease. - Hypotension: dangerously low blood pressure. - Allergic reactions: rash, itching, or swelling. - Liver enzyme elevations: abnormal liver function tests.

Nebivolol requires careful assessment before initiation and during therapy. - Cardiovascular assessment: evaluate heart rate, rhythm, and blood pressure before starting. - Concomitant β‑blockers: avoid combining with other β‑blockers to prevent excessive bradycardia. - Asthma or COPD: use with caution due to potential bronchospasm. - Diabetes mellitus: monitor blood glucose as β‑blockade may mask hypoglycaemia symptoms. - Pregnancy and lactation: safety not established; prescribe only if benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Nebivolol can interact with several drug classes, influencing its efficacy and safety.

Major Interactions (Avoid): - Strong CYP2D6 inhibitors (e.g., paroxetine, quinidine): may increase nebivolol plasma levels. - Non‑dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem): can cause additive bradycardia. - Other antihypertensives (e.g., ACE inhibitors, diuretics): may lead to excessive hypotension.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: β‑blockade may mask hypoglycaemia signs. - NSAIDs: may reduce antihypertensive effect. - Antidepressants (e.g., SSRIs): monitor for additive heart‑rate effects. - Digoxin: increased risk of bradyarrhythmias. - Alcohol: may enhance central nervous system depression and dizziness.